摘要:
The present invention provides powder fluidization additives for increasing flowability of fine powders. The powder fluidization additives have both a smaller size than the fine powder and a mean apparent particle density less than the mean apparent particle density of the fine powder. The particles of the additive act to separate the fine powder particles and reduce interparticle forces allowing the flowability of the fine powder to be increased.
摘要:
An ingress is coupled with the switch fabric to send flows of data across the switch fabric. Each of the flows of data is associated with a flow identification information and a priority level. An egress is coupled with the switch fabric to receive the flows of data from the ingress. The egress is configured to send one or more flow control messages to the ingress to control a pace that the ingress sends the flows of data to the egress. Each of the flow control messages includes one or more of a flow identification information, an egress space availability information and a new priority level for a flow.
摘要:
One approach to treating individuals infected with HIV-1 is to administer to such individuals compounds that directly interfere with and intervene in the machinery by which HIV-1 replicates itself within human cells. Although the specific role of HIV-1 viral protein Vif in the viral life cycle is not known, the vif gene is essential for the pathogenic replication of lentiviruses in vivo. The present invention relates to a method for treating an individual exposed to or infected with HIV-1. Individuals identified as being exposed to or infected by HIV-1 are administered a therapeutically effective amount of one or more compounds that inhibit or prevent replication of said HIV-1 by interfering with the replicative or other essential functions of HIV-1 viral protein Vif, by interactively blocking the multimerization domain of Vif, thereby preventing multimerization of Vif protein, which is important for Vif function in the lentivirus life cycle. In preferred embodiments, the compound or compounds that interactively block the multimerization domain of Vif are Vif antagonists. Pharmaceutical compositions comprising these compounds are also disclosed.
摘要:
Allocating resources in a content delivery environment is disclosed. An initial demand from initial clients for content is serviced by assigning those initial clients a first content source. A determination is made that additional demand from additional clients is either present or anticipated for the first content source. The initial demand and the additional demand together have a potential to overload the first content source. An interaction with a first initial client is adjusted to allow the additional demand to be at least partially serviced without overloading the content source.
摘要:
A solid electrolyte composite is provided comprising a NaSICON framework of the formula NaxAyBzP3−zOw wherein A is one or more metal ions, B is one or more ions having a pentavalence, and x is a number ranging from 1 to 12, y is a number ranging from 1 to 2, z is a number ranging from 0 to 3, and w is a number ranging from 4 to 12, wherein B is present or absent, and a glass material. A battery is disclosed having at least one cathode and anode and the solid electrolyte glass phase composite described above disposed between at least one of the anode and cathode. A method for making the solid electrolyte composite is set forth.
摘要:
Several attempts have been tried to improve the performance of intra-prediction in video encoding and decoding, which are targeting at pixel level parallelization. A solution for implementing an improved intra-prediction method on a parallel processing platform uses estimated predictors instead of reconstructed exact predictors. This enables faster estimation of predictors, and allows an encoder to perform intra-prediction for all blocks of at least a portion of an image simultaneously.
摘要:
Biocompatible polymeric coating compositions having nanoscale surface roughness and methods of forming such coatings are described. A polymeric biocompatible coating may be produced using a powder coating method, where one or more thermosetting polymer resins and one or more biocompatible materials are mixed and extruded, ground into microscale particles, and mixed with nanoparticles to form a dry powder mixture that may be coated onto a substrate according to a powder coating method. Alternatively, the thermosetting polymeric resin can be first extruded and ground into microscale particles, and then mixed with the biocompatible materials in particular form of nanoscale to microscale in size, and then further mixed with nanoparticles to form a dry powder mixture for coating. Bioactive materials may also be selectively added into the polymeric coating in a similar way as the biocompatible materials, either before or after the extrusion, to form a bioactive polymeric coating.
摘要:
A method of analyzing a wellbore fluid that includes treating a wellbore fluid with an emulsifying fluid, the emulsifying fluid comprising: a hydroxylated ether; an amphoteric chemotrope; and testing the treated wellbore fluid for at least one of turbidity and total suspended solids is disclosed. Methods of cleaning wellbores are also disclosed.
摘要:
Monitoring performance data associated with a content player is disclosed. Information relating to the state of a content player is obtained on a time driven basis. At least a portion of the obtained information is reported, via a communications interface, to a content distribution monitoring server.
摘要:
The present invention relates to 9-aminomethyl substituted tetracycline compounds represented by formula (I), or pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as well as a method for preparing these compounds and a pharmaceutical composition comprising the same. The present invention relates also to a use of these compounds in the preparation of a medicament for the treatment and/or prophylaxis of tetracycline drug-sensitive disease. wherein, R2a, R2b, R3, R4a, R4b, R5, R6a, R6b, R7, R8, R9a, R9b, R10, R11, R12, R13a and R13b are each independently as defined in the description.